P-148: Second booster BNT162b2 restores SARS-CoV-2 humoral response in patients with multiple myeloma, except for those under treatment with anti-BCMA agents

Detalles Bibliográficos
Autores principales: Ntanasis-Stathopoulos, Ioannis, Karalis, Vangelis, Gavriatopoulou, Maria, Sklirou, Aimilia D, Malandrakis, Panagiotis, Migkou, Magdalini, Roussou, Maria, Fotiou, Despina, Alexopoulos, Harry, Eleutherakis-Papaiakovou, Evangelos, Theodorakakou, Foteini, Kastritis, Efstathios, Trougakos, Ioannis P, Dimopoulos, Meletios A., Terpos, Evangelos
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Elsevier Inc. 2022
Materias:
Poster Presentations
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9403087/
http://dx.doi.org/10.1016/S2152-2650(22)00478-5

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9403087/
http://dx.doi.org/10.1016/S2152-2650(22)00478-5

Ejemplares similares